Age Related Macular Degeneration (AMD) is a worldwide public health challenge. It is by far the most common cause of sight loss in the developed world.
In spite of many advances in genetics, pathogenesis and epidemiology we do not know how to prevent the disease from progressing from the benign early stages to the advanced end stages involving debilitating sight losses in all cases.